Epsilon Healthcare Ltd.

Epsilon Healthcare Ltd. is a diversified healthcare and pharmaceutical company, specializing primarily in the development and manufacture of medicinal cannabis products. Founded in 2016 and based in Sydney, Australia, the company operates within the broader pharmaceuticals, biotechnology, and life sciences sector. Epsilon Healthcare Ltd. owns a portfolio of medicinal cannabis assets, positioning itself as a significant player in the emerging medical cannabis industry. The business model integrates pharmaceutical product manufacturing with a focus on medical applications of cannabis, serving healthcare providers, patients, and other industry stakeholders. Epsilon Healthcare’s activities also extend to hydroponics equipment, materials, and nutrient supply, supporting the cultivation and production needs of the medicinal cannabis sector. Its role in the market is underlined by a commitment to scientific research and product quality, aiming to address global demand for regulated, high-standard medical cannabis solutions. The company’s diverse operations reflect its mission to serve as a bridge between advanced healthcare innovation and patient care within an evolving industry landscape.